Financials
Financial year 2025
Guillaume Rosière Médecine Générale from Profondeville, company number BE0689847271, closed financial year 2025 with a result of € 89,264 after tax. For that financial year Guillaume Rosière Médecine Générale recorded a gross margin of € 152,433 and equity of € 227,292. Compared with financial year 2024, the result moved from € 79,229 to € 89,264. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.
€ 227,292
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 89,264
▲ 13% vs 2024
Profit after tax over the fiscal year.
€ 174,775
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 28,481
▲ 1% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,745
▼ 38% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,185
▼ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,888
▲ 7% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 121,952 | € 127,614 | € 139,334 | € 152,433 | ▲ 9% |
| Profit after taxes | € 79,331 | € 75,973 | € 79,229 | € 89,264 | ▲ 13% |
| Equity | € 236,188 | € 237,160 | € 238,028 | € 227,292 | ▼ 5% |
| Total debts | € 45,109 | € 88,584 | € 95,302 | € 105,256 | ▲ 10% |
| Cash | € 152,025 | € 179,597 | € 204,572 | € 174,775 | ▼ 15% |
| Retained profit | € 223,788 | € 224,760 | € 225,628 | € 214,892 | ▼ 5% |
| Dividend | € 800 | € 75,000 | € 78,362 | € 100,000 | ▲ 28% |
| Bank debt | € 27,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 281,297 | € 325,744 | € 333,330 | € 332,548 |
Key figures of Guillaume Rosière Médecine Générale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Guillaume Rosière Médecine Générale?
What happened at Guillaume Rosière Médecine Générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 89,264 (▲ 13% vs 2024). Source: NBB ↗
- New establishment in Profondeville. KBO
- Guillaume Rosière became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 79,331 profit in 2022 to € 89,264 profit in 2025.
Paid € 95,589 in corporate taxes since 2022.
Best year ever: 2025, with € 89,264 profit.
Paid out € 254,162 in dividends to the owners in total.
Management
Behind Guillaume Rosière Médecine Générale is Guillaume Rosière. It owns 50% of Norodoc SRL itself.
Directors
According to the 2025 annual accounts
Guillaume Rosière
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Rue Georges Pochet(LV) 39
5170 Profondeville
Rue Raymond Noel(B.V.) 121 box A
5170 Profondeville
Active since 6 February 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0689.847.271
- VAT number
- BE 0689.847.271
- Registered office
- Rue Georges Pochet(LV) 39, 5170 Profondeville
- Names & denominations
- Guillaume Rosière Médecine Générale
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 February 2018
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Activiteiten van huisartspraktijken